95 related articles for article (PubMed ID: 20631625)
41. Differential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donors.
MacParland SA; Corkum CP; Burgess C; Karwowska S; Kroll W; Michalak TI
Int Immunopharmacol; 2015 Apr; 25(2):545-52. PubMed ID: 25765354
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection.
Hou J; van Oord G; Groothuismink ZM; Claassen MA; Kreefft K; Zaaraoui-Boutahar F; van IJcken WF; Osterhaus AD; Janssen HL; Andeweg AC; de Knegt RJ; Boonstra A
J Virol; 2014 Nov; 88(21):12254-64. PubMed ID: 25100847
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha.
Scagnolari C; Zingariello P; Vecchiet J; Selvaggi C; Racciatti D; Taliani G; Riva E; Pizzigallo E; Antonelli G
Virol J; 2010 Nov; 7():311. PubMed ID: 21070682
[TBL] [Abstract][Full Text] [Related]
44. A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients.
Brodsky LI; Wahed AS; Li J; Tavis JE; Tsukahara T; Taylor MW
PLoS One; 2007 Jul; 2(7):e584. PubMed ID: 17589564
[TBL] [Abstract][Full Text] [Related]
45. Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy.
Kimball P; Elswick RK; Shiffman M
J Med Virol; 2001 Nov; 65(3):510-6. PubMed ID: 11596086
[TBL] [Abstract][Full Text] [Related]
46. Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.
Felger JC; Cole SW; Pace TW; Hu F; Woolwine BJ; Doho GH; Raison CL; Miller AH
Psychol Med; 2012 Aug; 42(8):1591-603. PubMed ID: 22152193
[TBL] [Abstract][Full Text] [Related]
47. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873
[TBL] [Abstract][Full Text] [Related]
48. Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray.
Sanayama Y; Ikeda K; Saito Y; Kagami S; Yamagata M; Furuta S; Kashiwakuma D; Iwamoto I; Umibe T; Nawata Y; Matsumura R; Sugiyama T; Sueishi M; Hiraguri M; Nonaka K; Ohara O; Nakajima H
Arthritis Rheumatol; 2014 Jun; 66(6):1421-31. PubMed ID: 24591094
[TBL] [Abstract][Full Text] [Related]
49. Relationship between response to interferon-alpha and function of peripheral blood mononuclear cells in chronic hepatitis C patients.
Esquivel F; Albillos A; Carrión F; Prieto A; Reyes E; Martínez-Martin B; Calleja JL; Cacho G; Alvarez-Mon M
Dig Dis Sci; 2002 Oct; 47(10):2154-62. PubMed ID: 12395886
[TBL] [Abstract][Full Text] [Related]
50. The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response.
Bolen CR; Robek MD; Brodsky L; Schulz V; Lim JK; Taylor MW; Kleinstein SH
J Interferon Cytokine Res; 2013 Jan; 33(1):15-23. PubMed ID: 23067362
[TBL] [Abstract][Full Text] [Related]
51. Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy.
Schlaak JF; Trippler M; Hoyo-Becerra C; Erim Y; Kis B; Wang B; Scherbaum N; Gerken G
PLoS One; 2012; 7(6):e38668. PubMed ID: 22701688
[TBL] [Abstract][Full Text] [Related]
52. Suppression of ribosomal protein synthesis and protein translation factors by Peg-interferon alpha/ribavirin in HCV patients blood mononuclear cells (PBMC).
Gupta R; Kim S; Taylor MW
J Transl Med; 2012 Mar; 10():54. PubMed ID: 22436241
[TBL] [Abstract][Full Text] [Related]
53. The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-alpha and ribavirin combined therapy for chronic hepatitis C patients.
Chen PJ; Hwang Y; Lin CG; Wu YJ; Wu LS
Int J Immunogenet; 2008 Apr; 35(2):153-7. PubMed ID: 18279371
[TBL] [Abstract][Full Text] [Related]
54. Activation of Type I and Type III Interferons in Chronic Hepatitis C.
Mihm S
J Innate Immun; 2015; 7(3):251-259. PubMed ID: 25766746
[TBL] [Abstract][Full Text] [Related]
55. Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C.
Balan V; Aravind L; Grill DE; Therneau TM; Sulkowski MS; Nelson DR; Praestgaard J; Rosati M; Birse CE; Moore PA; Mani Subramanian G
Hepatol Res; 2006 Dec; 36(4):277-87. PubMed ID: 17030011
[TBL] [Abstract][Full Text] [Related]
56. Two recombinant human interferon-beta 1a pharmaceutical preparations produce a similar transcriptional response determined using whole genome microarray analysis.
Prync AE; Yankilevich P; Barrero PR; Bello R; Marangunich L; Vidal A; Criscuolo M; Benasayag L; Famulari AL; Domínguez RO; Kauffman MA; Diez RA
Int J Clin Pharmacol Ther; 2008 Feb; 46(2):64-71. PubMed ID: 18218286
[TBL] [Abstract][Full Text] [Related]
57. An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load.
Wahid B; Rafique S; Saleem K; Ali A; Idrees M
J Interferon Cytokine Res; 2018 Mar; 38(3):122-128. PubMed ID: 29565742
[TBL] [Abstract][Full Text] [Related]
58. Ophthalmological side effects of interferon therapy of chronic hepatitis C.
Medhat E; Esmat G; Hamza E; Abdel Aziz A; Fouad Fathalah W; Darweesh SK; Zakaria Z; Mostafa S
Hepatobiliary Surg Nutr; 2016 Jun; 5(3):209-16. PubMed ID: 27275462
[TBL] [Abstract][Full Text] [Related]
59. The prediction of interferon treatment effects based on time series microarray gene expression profiles.
Huang T; Tu K; Shyr Y; Wei CC; Xie L; Li YX
J Transl Med; 2008 Aug; 6():44. PubMed ID: 18691426
[TBL] [Abstract][Full Text] [Related]
60. Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies.
Wang CH; Hwang Y; Lin E
J Exp Pharmacol; 2010; 2():73-82. PubMed ID: 27186094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
